LAZARD ASSET MANAGEMENT LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$16
-46.7%
1,799
+43.1%
0.00%
Q2 2023$30
-71.7%
1,257
-72.5%
0.00%
Q1 2023$106
-3.6%
4,571
+4.9%
0.00%
Q4 2022$110
-99.9%
4,357
+10.5%
0.00%
Q2 2022$100,000
+6.4%
3,943
+7.6%
0.00%
Q1 2022$94,000
+9300.0%
3,663
+11346.9%
0.00%
Q4 2021$1,000
-98.1%
32
-97.4%
0.00%
Q3 2021$54,000
+575.0%
1,250
+416.5%
0.00%
Q3 2020$8,0002420.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
SB INVESTMENT ADVISERS (UK) LTD 22,616,666$284,405,0003.12%
INDUS CAPITAL PARTNERS, LLC 681,936$8,575,0001.68%
Alphabet Inc. 1,666,666$20,958,0001.27%
Temasek Holdings (Private) Ltd 5,499,999$69,162,0000.45%
Board of Trustees of The Leland Stanford Junior University 38,905$490,0000.06%
Baillie Gifford 500,000$6,287,0000.01%
Marshall Wace North America L.P. 74,898$941,0000.01%
Capital International Investors 983,300$12,365,0000.00%
Blackstone Inc. 35,000$440,0000.00%
Tower Research Capital LLC (TRC) 1,908$24,0000.00%
View complete list of VIR BIOTECHNOLOGY INC shareholders